19 June : conference call to discuss the results of the phase IIa study in high blood pressure
Download the free guide
Boost your gains
June 27 : day opinion leaders (KOL’s – Key Opinion Leader) to New York (United States) open to investors and analysts
Quantum Genomics (Alternext – FR0011648971 – ALQGC), a biopharmaceutical company whose mission is to develop new therapies for unmet medical needs in the field of cardiovascular diseases, confirms the holding of two major events in the month of June 2017.
The company will be held on Monday, 19 June 2017 a conference call at the destination of the financial community to comment on the results of the phase IIa of the drug candidate QGC001, which have been the subject of a presentation yesterday on the occasion of the 27th European Congress on Hypertension and Cardiovascular Protection, organized by the European Society of Hypertension (ESH) in Milan from 16 to 19 June 2017.
Event : Conference call & webcast
Date : Monday, 19 June 2017
Schedule : 18: 00 (Paris time)
Link to the webcast : click here
Phone number : 08 00 90 23 49
Conference Code : 667-273-987
On Tuesday 27 June 2017, Quantum Genomics will host in New York (United States)a day opinion leaders (KOL’s Key Opinion Leader) open to investors and analysts. As a reminder, doctors, scholars will be speaking during this event : Henry Black, a Professor of medicine associate clinician and a member of the section of cardiology of the Faculty of medicine of the University of New York, and Keith C. Ferdinand, Professor of medicine at the Faculty of medicine of the University of Tulane. Lionel Ségard, Chairman and ceo of Quantum Genomics, and Bruno Besse, Medical Director, comment on the data of the phase IIa clinical trial in hypertension and the next clinical trial in the United States.
Event : Quantum Genomics KOL & Investor Day
Date : Tuesday, 27 June 2017
Schedule : 11: 00 – 14: 00 (New York time)
Location : Le Parker Meridien, 119 West 56th Street, New York, NY
RSVP : register with Tirth Patel (tpatel@edisongroup.com)
This conference will be recorded and available shortly after webcast for 90 days on the website of Quantum Genomics, www.quantum-genomics.com.
Lionel Ségard, Chairman and ceo of Quantum Genomics, says :
“Quantum Genomics is delighted to be presenting the clinical results of its phase IIa study in high blood pressure and its latest news to the investors of the two sides of the Atlantic, and in the world, in the space of a fortnight. We are at an important stage of the history of our company and willing to share with the financial community. “
Download the free guide
Boost your gains
